Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
Franco̧is Cornelis, Mary Beattie, Tomas Kirchhoff(Memorial Sloan Kettering Cancer Center), Trinidad Caldés(Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Ava Kwong(University of Hong Kong), Thomas van Overeem Hansen(University of Copenhagen), Tomasz Huzarski(International Hereditary Cancer Center), Hans Ehrencrona(Lund University), Noralane M. Lindor(Mayo Clinic in Arizona), Christoph Engel(University Hospital Leipzig), Andrew K. Godwin(The University of Melbourne), Soo‐Hwang Teo(Cancer Research Malaysia), María‐Isabel Tejada(BioCruces Health research Institute), Georgia Chenevix‐Trench(QIMR Berghofer Medical Research Institute), Evgeny N. Imyanitov(Saint Petersburg State Pediatric Medical University), Liliana Varesco(Istituti di Ricovero e Cura a Carattere Scientifico), Amanda E. Toland(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Elzbieta Zołwocka, Irene L. Andrulis(University of Toronto), Jacques Simard(Université Laval), Ramūnas Janavičius(Vilnius University), Christian Sutter(Heidelberg University), Mary Beth Terry(Columbia University Irving Medical Center), Susan M. Domchek(University City Science Center), Wendy S. Rubinstein(National Cancer Institute), Olivier Caron(Université Paris-Saclay), Saundra S. Buys(University of Utah), Hanne Meijers‐Heijboer(German Cancer Research Center), Dieter Niederacher(Heinrich Heine University Düsseldorf), Bernard Peissel(Sapienza University of Rome), Xianshu Wang(Kunming University of Science and Technology), D. Gareth Evans(Manchester Academic Health Science Centre), Maura Kennedy(Harvard University), Per Karlsson(University of Gothenburg), Patricia A. Ganz(Los Angeles County Department of Public Health), Paolo Peterlongo(IFOM), Monica Barile(European Institute of Oncology), Isabelle Coupier(Inserm), Mary Porteous(University of Edinburgh), Lesley McGuffog(University of Cambridge), Simona Agata(Istituto Oncologico Veneto), Sue Healey(QIMR Berghofer Medical Research Institute), Mads Thomassen(Odense University Hospital), Muy Kheng M. Tea, Elena Fineberg, Anna von Wachenfeldt(Karolinska Institutet), Maria A. Caligo(Azienda Ospedaliera Universitaria Pisana), Torben A. Kruse(Odense University Hospital), Elizabeth J. van Rensburg(University of Pretoria)
Cited by 2
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Mortality Results from a Randomized Prostate-Cancer Screening Trial
|New England Journal of Medicine|2009|2.9k